Live Markets
DJI
52,286.55
−0.14%
GSPC
7,686.97
+0.13%
IXIC
26,247.41
+0.30%
RUT
2,797.17
+0.39%
FTSE
10,660.02
−1.00%
GDAXI
25,449.88
+0.15%
FCHI
7,869.80
+0.29%
STOXX50E
6,130.08
+0.23%
XLE
69.11
−0.76%
XLF
55.85
−0.29%
DJI
52,286.55
−0.14%
GSPC
7,686.97
+0.13%
IXIC
26,247.41
+0.30%
RUT
2,797.17
+0.39%
FTSE
10,660.02
−1.00%
GDAXI
25,449.88
+0.15%
FCHI
7,869.80
+0.29%
STOXX50E
6,130.08
+0.23%
XLE
69.11
−0.76%
XLF
55.85
−0.29%
Tuesday, October 27, 2026
·
George Town, KY
·
29°
·
Partly Cloudy
Markets Open · NYSE
·
Newsletter
·
Masthead
·
Sign In
VOL. XII · NO. 117
Established MMXIV · George Town, Grand Cayman
Atlantic Edition · $4.50
The
Cayman
Journal
Finance · Business · Technology · Caribbean & Global Affairs
⌕
Research
Markets
13F
Insiders
Press Releases
Companies
People
Real Estate
Yacht
AI Agents + MCP
Business
Economy
Markets & Finance
Research Reports
Technology
Insider · CIK 0001691428
UBS Oncology Impact Fund L.P.
Follow
Positions
Werewolf Therapeutics, Inc.
·
HOWL
(10 filings)
iTeos Therapeutics, Inc.
·
ITOS
(1 filing)
Recent Filings (3)
Dec 1, 2025
Form 4
Werewolf Therapeutics, Inc.
-141,927 sh
Nov 12, 2025
Form 4
Werewolf Therapeutics, Inc.
-213,529 sh
Oct 29, 2025
Form 4
Werewolf Therapeutics, Inc.
-276,017 sh